We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Novartis has agreed to pay a tentative settlement of $390 million in a whistleblower’s lawsuit alleging the company received kickbacks from pharmacies to promote products, ending a four-year-old case. Read More
Democratic presidential candidate Hillary Clinton joined the growing chorus of lawmakers and others outraged over Turing Pharmaceuticals’ price hike on Daraprim, pressing the FDA and FTC on Oct. 19 to broaden access to less expensive drugs. Read More
Swiss-based Helsinn Healthcare has settled patent litigation with Dr. Reddy’s Laboratories, allowing the Indian genericsmaker to sell a generic version of the anti-nausea injection Aloxi starting in 2018. Read More
Sun Pharmaceuticals has quietly dropped an appeal of a lawsuit challenging the FDA’s authority to revoke the tentative approval of two generics made by its Ranbaxy subsidiary. Read More
A federal appeals court has refused to rehear the biosimilars case pitting Sandoz against Amgen, letting stand a July decision allowing Sandoz to launch its Zarxio biosimilar of Amgen’s cancer therapy Neupogen (filgrastim) in September. Read More
Valeant Pharmaceuticals is defending its business relationship with specialty pharmacy Philidor RX Services against allegations Valeant used it to inflate financial results. Read More